DOI:
10.1055/s-00000022
Das Gesundheitswesen
LinksClose Window
References
Hannouf MB, Xie B, Brackstone M et al.
Cost Effectiveness of a 21-Gene Recurrence Score Assay Versus Canadian Clinical Practice in Post-Menopausal Women with Early-Stage Estrogen or Progesterone-Receptor-Positive, Axillary Lymph-Node Positive Breast Cancer.
Pharmacoeconomics 2014;
32: 135-147
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.